BRD4 and viral infectious disease: It has been described that following RSV viral infection, the BRD4/RELA complex recruits the P-TEFb component CDK9 to IRF1 and IRF7 promoters for enhanced expression, and BRD4 inhibition has proven to alleviate viral-associated inflammation in this system [212].